scholarly journals Correction to: LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification

Author(s):  
Pingfu Hou ◽  
Sen Meng ◽  
Minle Li ◽  
Tian Lin ◽  
Sufang Chu ◽  
...  
2014 ◽  
Vol 12 (1) ◽  
pp. 109 ◽  
Author(s):  
Min-Hui Yang ◽  
Jiang Yu ◽  
Dong-Mei Jiang ◽  
Wen-Lu Li ◽  
Shuang Wang ◽  
...  

2018 ◽  
Vol 50 (5) ◽  
pp. 1-17 ◽  
Author(s):  
Yong Wang ◽  
Zhi Lu ◽  
Ningnin Wang ◽  
Jianzhou Feng ◽  
Junjie Zhang ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (35) ◽  
pp. 59246-59256 ◽  
Author(s):  
Fangbing Zhai ◽  
Chunhong Cao ◽  
Liang Zhang ◽  
Jianhua Zhang

2018 ◽  
Vol 422 ◽  
pp. 56-69 ◽  
Author(s):  
Wendi Shuai ◽  
Jiangxue Wu ◽  
Shuai Chen ◽  
Ranyi Liu ◽  
Zhihua Ye ◽  
...  

2019 ◽  
Author(s):  
Er-Bao Chen ◽  
Xuan Qin ◽  
Ke Peng ◽  
Qian Li ◽  
Cheng Tang ◽  
...  

Author(s):  
Zizhen Si ◽  
Lei Yu ◽  
Haoyu Jing ◽  
Lun Wu ◽  
Xidi Wang

Abstract Background Long non-coding RNAs (lncRNA) are reported to influence colorectal cancer (CRC) progression. Currently, the functions of the lncRNA ZNF561 antisense RNA 1 (ZNF561-AS1) in CRC are unknown. Methods ZNF561-AS1 and SRSF6 expression in CRC patient samples and CRC cell lines was evaluated through TCGA database analysis, western blot along with real-time PCR. SRSF6 expression in CRC cells was also examined upon ZNF561-AS1 depletion or overexpression. Interaction between miR-26a-3p, miR-128-5p, ZNF561-AS1, and SRSF6 was examined by dual luciferase reporter assay, as well as RNA binding protein immunoprecipitation (RIP) assay. Small interfering RNA (siRNA) mediated knockdown experiments were performed to assess the role of ZNF561-AS1 and SRSF6 in the proliferative actives and apoptosis rate of CRC cells. A mouse xenograft model was employed to assess tumor growth upon ZNF561-AS1 knockdown and SRSF6 rescue. Results We find that ZNF561-AS1 and SRSF6 were upregulated in CRC patient tissues. ZNF561-AS1 expression was reduced in tissues from treated CRC patients but upregulated in CRC tissues from relapsed patients. SRSF6 expression was suppressed and enhanced by ZNF561-AS1 depletion and overexpression, respectively. Mechanistically, ZNF561-AS1 regulated SRSF6 expression by sponging miR-26a-3p and miR-128-5p. ZNF561-AS1-miR-26a-3p/miR-128-5p-SRSF6 axis was required for CRC proliferation and survival. ZNF561-AS1 knockdown suppressed CRC cell proliferation and triggered apoptosis. ZNF561-AS1 depletion suppressed the growth of tumors in a model of a nude mouse xenograft. Similar observations were made upon SRSF6 depletion. SRSF6 overexpression reversed the inhibitory activities of ZNF561-AS1 in vivo, as well as in vitro. Conclusion In summary, we find that ZNF561-AS1 promotes CRC progression via the miR-26a-3p/miR-128-5p-SRSF6 axis. This study reveals new perspectives into the role of ZNF561-AS1 in CRC.


Sign in / Sign up

Export Citation Format

Share Document